Skip to main content

Table 1 Comparison of mean survival time in different mouse groups after AOM (100 μg/g, i.p.) injection

From: Protective role of VEGF/VEGFR2 signaling against high fatality associated with hepatic encephalopathy via sustaining mitochondrial bioenergetics functions

Group

Mean survival time (h)

p value

VEGFR2 wild-type

35.5 ± 3.5 (n = 10)

 

VEGFR2 heterozygous

28.5 ± 3.6 (n = 10)

p = 0.1805

C57BL/6 (i.c.v.)

 IgG

38.5 ± 1.7 (n = 10)

 

 VEGF Ab

29.1 ± 2.3 (n = 10)*

p = 0.0041

  1. Values are mean ± SEM
  2. *p < 0.05 versus corresponding control group in the Student’s t-test